Literature DB >> 7658497

Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

G Y Ho1, R D Burk, S Klein, A S Kadish, C J Chang, P Palan, J Basu, R Tachezy, R Lewis, S Romney.   

Abstract

BACKGROUND: Cervical dysplasia, also referred to as squamous intraepithelial lesion (SIL) in cytology or cervical intraepithelial neoplasia in histopathology, is thought to have the potential to advance in progressive stages to cervical cancer. However, not all cases of SIL progress, and most of the mild lesions spontaneously regress. Factors that govern regression, persistence, and progression of SIL are poorly understood.
PURPOSE: Our analysis sought to identify factors that determined persistence or regression of SIL.
METHODS: Seventy subjects with histopathologically confirmed cervical dysplasia were followed at 3-month intervals for 15 months. At each visit, the cervix was evaluated by Pap smear and colposcopy, and exfoliated cervicovaginal cells were analyzed for human papillomavirus (HPV) DNA. For each subject, data from every two consecutive visits were grouped as a pair. Persistent SIL was considered present if a lesion was detected at a visit (t) as well as at the next visit (t + 1) and absent if a lesion was detected at visit t but not at visit t + 1. A statistical model for time-dependent data correlated persistent SIL with various risk factors.
RESULTS: Age, ethnicity, education, sexual behavior, smoking, and the use of oral contraceptives did not correlate with persistent SIL. The risk of persistent SIL was associated with continual HPV infection in visits t and t + 1 (HPV positive by Southern blot analysis: odds ratio [OR] = 3.91, and 95% confidence interval [CI] = 1.58-9.65; HPV positive by polymerase chain reaction [PCR]: OR = 2.42, and 95% CI = 1.03-5.67) and a persistent high viral load (OR = 4.07, and 95% CI = 1.35-12.30). When typed by PCR, individuals with type-specific persistent infection in visits t and t + 1, and particularly those with a continual high viral load (OR = 4.97; 95% CI = 1.45-17.02), had the highest risk for persistent SIL compared with those with a low level of type-specific persistent infection or non-type-specific persistent infection. The presence of persistent HPV infection in visits t-1 (the preceding time interval) was also predictive of persistent SIL in visits t and t + 1, although the strength of association was weaker, suggesting that persistent HPV and SIL occur synchronously.
CONCLUSION: HPV infection and its associated cervical lesions tend to occur concurrently, and type-specific persistent HPV infection, particularly with a high viral load, produces chronic cervical dysplasia. IMPLICATIONS: The natural history of genital HPV infection directly influences the prognosis of cervical dysplasia as measured by persistence of the lesion. Testing for HPV infection may be valuable in the clinical management of women with cervical dysplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658497     DOI: 10.1093/jnci/87.18.1365

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  156 in total

1.  Screening for cervical cancer: should we test for infection with high-risk HPV?

Authors:  C J Meijer; P J Snijders; A J van den Brule
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

2.  Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer.

Authors:  Morgan A Marks; Philip E Castle; Mark Schiffman; Patti E Gravitt
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

3.  Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting.

Authors:  Sarah Coseo Markt; Ana C Rodriguez; Robert D Burk; Allan Hildesheim; Rolando Herrero; Sholom Wacholder; Martha Hutchinson; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

Review 4.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

5.  Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; Zhonghu He; Rachel L Winer; Ayaka Hulbert; Shu-Kuang Lee; Yang Ke; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2012-07-11       Impact factor: 7.396

6.  The females against cancer educational series: a qualitative evaluation of mother/daughter knowledge and perceptions of human papillomavirus and its related cancers.

Authors:  Tasha R Louis-Nance; Minnjuan W Flournoy; Karen S Clinton; Krystle Hightower; Neethu Sebastian; Larrell L Wilkinson; Saundra H Glover
Journal:  J Natl Med Assoc       Date:  2012 Mar-Apr       Impact factor: 1.798

Review 7.  Our approach to squamous intraepithelial lesions of the uterine cervix.

Authors:  Alexandra N Kalof; Kumarasen Cooper
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

8.  Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts.

Authors:  G Gross; H Pfister
Journal:  Med Microbiol Immunol       Date:  2003-06-28       Impact factor: 3.402

9.  Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses.

Authors:  Yevgeniy Y Studentsov; Gloria Y F Ho; Morgan A Marks; Robert Bierman; Robert D Burk
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.

Authors:  P Zazove; B D Reed; L Gregoire; A Ferenczy; D W Gorenflo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.